SERINC2 and glioblastoma: The present study used the RNA sequencing and microarray data from TCGA and GEO and IHC staining from the HPA and found that the mRNA and protein expression levels of SERINC2 were higher in glioma than in brain tissues and that GBM had the highest SERINC2 expression.